Read more at MarketWatch.
Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock’s a buy.
Date: |
Sort by
Filter
Date
Items per page
-
How one state is trying to make weight loss drugs cheaper
Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.NBC News - Top stories -
Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, ...The Hill - Politics -
Insurers scale back reimbursements for drugs used for weight loss
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.NBC News - Top stories -
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
New weight loss drugs are reshaping a dieting industry built on eating less and exercising moreABC News - Health -
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.MarketWatch - Business -
Alphabet’s stock surges on Triple Crown of first-ever cash dividend, $70 billion stock buyback, strong results
Google parent Alphabet Inc.’s stock soared 12% in after-hours trading Thursday following huge spikes in revenue and net income that trounced analysts’ predictions — as well as its first-ever cash dividend of 20 cents per share.MarketWatch - Business -
Humana’s stock falls as earnings outlook to remain unclear for months
Humana’s stock turned lower Wednesday, after the health insurer reported a quarterly profit that beat expectations by a wide margin and boosted its outlook for Medicare Advantage membership growth, but said uncertainty over the earnings outlook ...MarketWatch - Business -
IBM’s stock heads toward its worst day since 2021 after earnings
IBM’s earnings showed continued AI momentum, though overall revenue came in a bit light.MarketWatch - Business -
Jefferies boss sells $65mn in stock to buy a customer’s yacht
Purchase shines light on wealth accumulated by longtime chief executive Rich HandlerFinancial Times - Business -
The timing may be just right to buy Nvidia or other semiconductor stocks
So far this year, the PHLX Semiconductor Index has increased 8.7% (with dividends reinvested), but it has declined 7.7% in April. Meanwhile, shares of industry star Nvidia Inc. have declined 12% this month.MarketWatch - Business
More from MarketWatch
-
‘We were all set to enjoy our retirement’: My son invested in startups and we bailed him out with $100,000. What now?
“When we agreed to help, it was with the understanding that this debt would be paid back with his share of inheritance.”MarketWatch - Business -
20 companies screened for quality in a cheap part of the stock market
Small-cap and midcap U.S. stocks are trading relatively low to historical price-to-earnings valuations, in contrast to the large-cap S&P 500.MarketWatch - Business -
Why you shouldn’t be too quick to dump your stocks
Sectors that typically rally at the end of bull markets are lagging.MarketWatch - Business -
The timing may be just right to buy Nvidia or other semiconductor stocks
So far this year, the PHLX Semiconductor Index has increased 8.7% (with dividends reinvested), but it has declined 7.7% in April. Meanwhile, shares of industry star Nvidia Inc. have declined 12% this month.MarketWatch - Business -
Worried about the volatility in Magnificent Seven stocks? Take a look at the companies’ short-dated bonds.
As their stocks sell off, Magnificent Seven companies’ two-year bonds are looking attractive.MarketWatch - Business